NTRA Q1 2025 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q1 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$502M+36.5% YoY

Gross Profit

$317M63.2% margin

Operating Income

-$79M-15.8% margin

Net Income

-$67M-13.3% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

$23M

Stock-Based Comp.

$78M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$493M

Stockholders' Equity

$1.2B

Cash & Equivalents

$974M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$502M	$368M	+36.5%
Gross Profit	$317M	$209M	+52.1%
Operating Income	-$79M	-$74M	-6.5%
Net Income	-$67M	-$68M	+1.0%

Revenue Segments

Product

$500M100%

Licensing and other

$2M0%

Geographic Segments

United States

$492M98%

Europe, Middle East, India, Africa

$6M1%

Asia Pacific and Other

$2M0%

Americas, excluding U.S.

$2M0%